Vevo Therapeutics that is combining in vivo data generated at scale with AI to find better targets and drugs to treat more patients.
Vevo Therapeutics, a biotechnology startup, searches for better treatments for more patients using their Mosaic in vivo drug discovery platform and next-generation AI algorithms.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 8, 2022 | Seed | $12M | 1 | General Catalyst | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
General Catalyst | Yes | Seed |